Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
New collaboration may lead to future clinical trials to test treatment for leukemia

New collaboration may lead to future clinical trials to test treatment for leukemia

Her genetic test revealed a microscopic problem — and a jumbo price tag

Her genetic test revealed a microscopic problem — and a jumbo price tag

Oral apixaban as effective as dalteparin for treating blood clots in people with cancer

Oral apixaban as effective as dalteparin for treating blood clots in people with cancer

Research could open up new therapeutic strategies for some lung and kidney cancers

Research could open up new therapeutic strategies for some lung and kidney cancers

Weakness in lung and kidney cancer cells could serve as therapeutic target

Weakness in lung and kidney cancer cells could serve as therapeutic target

Roscovitine enhances nuclear enrichment of traditionally cytoplasmic signaling molecules

Roscovitine enhances nuclear enrichment of traditionally cytoplasmic signaling molecules

Despite failures, chemotherapy still promising against fatal pediatric brain cancer

Despite failures, chemotherapy still promising against fatal pediatric brain cancer

YAP signal pathway plays a vital role in the onset of head-and-neck cancer

YAP signal pathway plays a vital role in the onset of head-and-neck cancer

Penn State engineers model genetic mutations causing drug resistance

Penn State engineers model genetic mutations causing drug resistance

3D chromatin landscapes in T cell acute lymphoblastic leukemia important beyond DNA code changes

3D chromatin landscapes in T cell acute lymphoblastic leukemia important beyond DNA code changes

Changes in 3D genetic structure equally important as DNA code mutations in childhood leukemia

Changes in 3D genetic structure equally important as DNA code mutations in childhood leukemia

A review of the literature on acute promyelocytic leukemia

A review of the literature on acute promyelocytic leukemia

Preclinical study characterizes the binding affinity and selectivity of a selective FLT3 inhibitor

Preclinical study characterizes the binding affinity and selectivity of a selective FLT3 inhibitor

Revolutionary technology could help identify more effective cancer drug combinations

Revolutionary technology could help identify more effective cancer drug combinations

Immunotherapy combination can shrink viral reservoir in HIV model

Immunotherapy combination can shrink viral reservoir in HIV model

Genetic test could help doctors to identify patients with ultra high risk multiple myeloma

Genetic test could help doctors to identify patients with ultra high risk multiple myeloma

The second person cured from HIV goes public

The second person cured from HIV goes public

New 'Immuno-Engineering to Improve Immunotherapy' Center formed to advance cancer therapy

New 'Immuno-Engineering to Improve Immunotherapy' Center formed to advance cancer therapy

Newly identified genetic signatures in common pediatric cancer pave way for precision medicine

Newly identified genetic signatures in common pediatric cancer pave way for precision medicine

Subpopulations of leukemic cells present at diagnosis can cause relapse in children with ALL

Subpopulations of leukemic cells present at diagnosis can cause relapse in children with ALL